NEW YORK (GenomeWeb) — Constellation Alpha Capital, a special purpose acquisition company, announced today that it has signed a non-binding letter of intent to acquire DermTech.
NEW YORK (GenomeWeb) — Constellation Alpha Capital, a special purpose acquisition company, announced today that it has signed a non-binding letter of intent to acquire DermTech.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.